Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
In accord with these findings, the overall levels of CASR, vitamin D receptor (VDR) and Klotho (KL), which are known to negatively regulate PTH production and secretion, were increased in PACs (Figure 2E). 35 , 36 The reduction in PTH and the increase in CASR in PACs were reflected in their protein expression levels, as detected using IHC in independent FFPE PA and PG tissues (Figure S3C: F).
Source: A pervasive increase in transcriptional activity in PACs. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Other blinding reported · Mixed research settings
Reported blinded roles: investigators.
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
All sporadic PA patients were diagnosed on the basis of standard clinical and biochemical parameters, including serum calcium and PTH levels as well as ultrasonographic examination, in the absence of other possible causes of hypercalcaemia (Figure ).
Source: Methods.
Examination of slides were performed by two independent investigators who were blinded to the sample grouping.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma
Study design awaiting verification · Clinical and Translational Medicine · 2024
Original publication title
KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma
© 2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Sporadic parathyroid adenoma (PA) is the most common cause of hyperparathyroidism, yet the mechanisms involved in its pathogenesis remain incompletely understood.
Source: BackgroundAbstract: What methods does the paper describe?
Surgically removed PA samples, along with normal parathyroid gland (PG) tissues that were incidentally dissected during total thyroidectomy, were analysed using single‐cell RNA‐sequencing with the 10× Genomics Chromium Droplet platform and Cell Ranger software. Gene set variation analysis was conducted to characterise hallmark pathway gene signatures, and single‐cell regulatory network inference and clustering were utilised to analyse transcription factor regulons. Immunohistochemistry and immunofluorescence were performed to validate cellular components of PA tissues. siRNA knockdown and gene overexpression, alongside quantitative polymerase chain reaction, Western blotting and cell proliferation assays, were conducted for functional investigations.
Source: MethodsAbstract: Highlights
Single‐cell RNA‐sequencing reveals a transcriptome catalogue comparing sporadic parathyroid adenomas (PAs) with normal parathyroid glands.
PA cells show a pervasive increase in gene expression linked to KMT2A upregulation.
KMT2A‐mediated STAT3 and GATA3 upregulation is key to promoting PA cell proliferation via cyclin D2.
PAs exhibit a proinflammatory microenvironment, suggesting a potential role of chronic inflammation in PA pathogenesis.
Abstract: Results
There was a pervasive increase in gene transcription in PA cells (PACs) compared with PG cells. This is associated with high expression of histone‐lysine N‐methyltransferase 2A (KMT2A). High KMT2A levels potentially contribute to promoting PAC proliferation through upregulation of the proto‐oncogene CCND2, which is mediated by the transcription factors signal transducer and activator of transcription 3 (STAT3) and GATA binding protein 3 (GATA3). PA tissues are heavily infiltrated with myeloid cells, while fibroblasts, endothelial cells and macrophages in PA tissues are commonly enriched with proinflammatory gene signatures relative to their counterparts in PG tissues.
Source: ResultsAbstract: Conclusions
We revealed the previously underappreciated involvement of the KMT2A: STAT3/GATA3: CCND2 axis and chronic inflammation in the pathogenesis of PA. These findings underscore the therapeutic promise of KMT2A inhibition and anti‐inflammatory strategies, highlighting the need for future investigations to translate these molecular insights into practical applications.
Source: ConclusionsAuthors’ abstract
Abstract
Background
Sporadic parathyroid adenoma (PA) is the most common cause of hyperparathyroidism, yet the mechanisms involved in its pathogenesis remain incompletely understood.
Methods
Surgically removed PA samples, along with normal parathyroid gland (PG) tissues that were incidentally dissected during total thyroidectomy, were analysed using single‐cell RNA‐sequencing with the 10× Genomics Chromium Droplet platform and Cell Ranger software. Gene set variation analysis was conducted to characterise hallmark pathway gene signatures, and single‐cell regulatory network inference and clustering were utilised to analyse transcription factor regulons. Immunohistochemistry and immunofluorescence were performed to validate cellular components of PA tissues. siRNA knockdown and gene overexpression, alongside quantitative polymerase chain reaction, Western blotting and cell proliferation assays, were conducted for functional investigations.
Results
There was a pervasive increase in gene transcription in PA cells (PACs) compared with PG cells. This is associated with high expression of histone‐lysine N‐methyltransferase 2A (KMT2A). High KMT2A levels potentially contribute to promoting PAC proliferation through upregulation of the proto‐oncogene CCND2, which is mediated by the transcription factors signal transducer and activator of transcription 3 (STAT3) and GATA binding protein 3 (GATA3). PA tissues are heavily infiltrated with myeloid cells, while fibroblasts, endothelial cells and macrophages in PA tissues are commonly enriched with proinflammatory gene signatures relative to their counterparts in PG tissues.
Conclusions
We revealed the previously underappreciated involvement of the KMT2A: STAT3/GATA3: CCND2 axis and chronic inflammation in the pathogenesis of PA. These findings underscore the therapeutic promise of KMT2A inhibition and anti‐inflammatory strategies, highlighting the need for future investigations to translate these molecular insights into practical applications.
Highlights
Single‐cell RNA‐sequencing reveals a transcriptome catalogue comparing sporadic parathyroid adenomas (PAs) with normal parathyroid glands.
PA cells show a pervasive increase in gene expression linked to KMT2A upregulation.
KMT2A‐mediated STAT3 and GATA3 upregulation is key to promoting PA cell proliferation via cyclin D2.
PAs exhibit a proinflammatory microenvironment, suggesting a potential role of chronic inflammation in PA pathogenesis.
Publication and source details
Original title: KMT2A and chronic inflammation as potential drivers of sporadic parathyroid adenoma
Qin Xu; Ting La; Kaihong Ye; Li Wang; Shasha Wang; Yifeng Hu; Liu Teng; Lei Yan; Jinming Li; Zhenhua Zhang; Zehua Shao; Yuan Yuan Zhang; Xiao Hong Zhao; Yu Chen Feng; Lei Jin; Mark Baker; Rick F. Thorne; Xu Dong Zhang; Feng‐Min Shao; Huixia Cao
Clinical and Translational Medicine · 2024
* CorrespondenceXu Dong Zhang, Feng‐Min Shao and Huixia Cao, University of Newcastle, LS3‐49, Life Science Building, Callaghan, NSW, Australia.
Email: Xu.Zhang@newcastle.edu.au, fengminshao@126.com and huixiacao310@126.com
© 2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.National Natural Science Foundation of China 10.13039/5011000018098200257182372638National Key Research and Development Program of China 10.13039/5011000121662018YFC1311202Talent Project of Henan Provincial People's Hospital, Major Public Welfare Projects in Henan Province201300310700Medical Science and Technology Project of Henan Province, ChinaHGJ20190615SBGJ2018062National Health and Medical Research Council 10.13039/501100000925APP2016686Cancer Council NSW Project Grant, AustraliaRG21‐10
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T11:12:02.856686+00:00
DOI: 10.1002/ctm2.1734 · PMC11185127